Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity
In the STEP1 trial (100), Wilding et al
This viewpoint promotes a transition from viewing GLP-1 RAs in a disease-specific manner to a more comprehensive understanding of whether these drugs impact various aging hallmark processes, including mitochondrial dysfunction, impaired proteostasis, and the decline in stem and progenitor cell functionelements that contribute to the diminished functional reserve seen with aging
This article covers exactly how peptide structure determines half-life, what reconstitution and storage errors collapse bioavailability before injection ever occurs, and why understanding the tesamorelin + ipamorelin blend half life is the single most important variable in designing effective research protocols
Scientific Researcher, DTP II, ORS, OGD, CDER, FDA Dr